While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.

On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...

(Bloomberg) — Merck KGaA forecast rising profit this year as its life science ... boost could come from a potential acquisition of cancer and rare diseases drugmaker SpringWorks Therapeutics Inc., for ...

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

One of the most significant developments for SpringWorks is the ongoing merger and acquisition discussions with Merck KGaA. Analysts view this potential acquisition as strategically sound for ...

Notably, there has been speculation about a potential acquisition of SpringWorks by Merck (NSE:PROR) KGaA. Analysts view this potential acquisition as strategically sound for several reasons: 1. There ...

German chemical and pharma group Merck KGaA has acknowledged that it is in talks to buy US biotech SpringWorks, but cautioned there is no guarantee a deal will be forthcoming. Merck said in a ...